scTransMIL bridges patient-level disease states and single-cell transcriptomics for cancer screening and heterogeneity inference
It is demonstrated that scTransMIL accurately predicts sample-level cancer phenotypes, including the tissue-of-origin for metastatic tumors, and robustly identifies tumor-associated cell populations and maps biological progression trajectories using only minimal sample-level annotations.